Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

May 25, 2022 at 3:00 PM EDT
H.C. Wainwright Global Investment Conference Sign up
May 17, 2022 at 10:00 AM EDT
RBC Capital Markets Global Healthcare Conference Sign up
March 16, 2022 at 8:00 AM EDT
Oppenheimer 32nd Annual Healthcare Conference Sign up